Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GILD
Stock Latest News
Weekend Updates
Why Gilead Sciences Is Suddenly Back in the Spotlight
1d ago
GILD
Premium
The Fly
Gilead announces NEJM Phase 3 study data for Trodelvy+Keytruda
4d ago
GILD
Premium
Market News
AbbVie (ABBV) Commits $100B in U.S. Investment, Inks Deal with Trump to Avoid Tariffs
12d ago
MRK
ABBV
Premium
The Fly
H.C. Wainwright says Vir’s SOLSTICE 96-week data reinforces best-in-class
12d ago
VIR
GILD
Premium
Ratings
Gilead Sciences: Durable HIV Leadership and De‑Risking Oncology Pipeline Support Compelling Buy-Rated Risk‑Reward
12d ago
GILD
Premium
The Fly
Gilead price target lowered to $150 from $151 at Morgan Stanley
12d ago
GILD
Premium
The Fly
Largest borrow rate increases among liquid names
13d ago
ITB
NVO
Premium
The Fly
Argenx appoints Sandrine Piret-Gerard chief commercialization officer
13d ago
ARGX
GILD
Premium
Weekend Updates
Halliburton, Schlumberger, SoFi, Procter, Gilead Trending
15d ago
PG
HAL
Premium
The Fly
Gilead price target raised to $154 from $144 at BofA
16d ago
GILD
Premium
The Fly
Gilead voluntarily recalls one lot of Veklury for Injection 100 mg/vial
17d ago
GILD
Premium
Market News
BKNG, GILD, ADI: 3 Stocks Flashing Strong Buy Signals on Technical Charts
17d ago
ADI
BKNG
Premium
The Fly
Gilead price target raised to $140 from $135 at Citi
18d ago
GILD
Premium
The Fly
Gilead assumed with Buy from Neutral at UBS
18d ago
GILD
Premium
Ratings
Gilead Sciences: PrEP-Led Growth, Easing HIV Overhangs, and Pipeline Upside Support Buy Rating and 2027 Re-Rating Target
18d ago
GILD
Premium
The Fly
Repare Therapeutics announces Gilead to acquire RP-3467 for up to $30M
1M ago
GILD
RPTX
Premium
The Fly
Early notable gainers among liquid option names on December 23rd
1M ago
ALB
AME
Premium
The Fly
Trump Trade: Trump strikes deals with nine drugmakers to cut prices
1M ago
CI
BMY
Premium
The Fly
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
1M ago
ASMB
GILD
Premium
The Fly
Gilead exercises option to license Assembly helicase-primase inhibitor programs
1M ago
ASMB
GILD
Premium
The Fly
Trump announces pacts with nine pharma companies to lower drug prices
1M ago
BMY
GSK
Premium
The Fly
Gilead reaches agreement with U.S. to lower drug costs for Americans
1M ago
GILD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.